Susan Cohen
Obstetrics & Gynecology · Los Angeles, CANPI 1285758433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $830 and has fallen 70.8% since, to $243 in 2025.
Across 139 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$586
- Therapeuticsmd, Inc.$354
- Exeltis, USA Inc.$308
- Mayne Pharma Commercial LLC$184
- Evofem Biosciences, Inc.$176
- Astellas Pharma US Inc$163
- plus $929 from 18 others
What the payments were for
- Food & beverage$2,65698%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $586 |
| Therapeuticsmd, Inc. | 23 | $354 |
| Exeltis, USA Inc. | 14 | $308 |
| Mayne Pharma Commercial LLC | 7 | $184 |
| Evofem Biosciences, Inc. | 14 | $176 |
| Astellas Pharma US Inc | 8 | $163 |
| Sage Therapeutics, LLC | 8 | $150 |
| Pfizer | 6 | $136 |
| Myovant Sciences Inc. | 6 | $112 |
| Agile Therapeutics, Inc. | 5 | $111 |
| Bayer | 3 | $71 |
| Shield Therapeutics Inc | 2 | $51 |
| Scynexis, Inc. | 2 | $44 |
| AMAG Pharmaceuticals, Inc. | 2 | $43 |
| Avanos Medical | 1 | $32 |
| Lupin Inc. | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Duchesnay USA Incorporated | 1 | $23 |
| Gilead | 1 | $19 |
| Merck | 1 | $19 |
| Millicent US Inc | 1 | $18 |
| Avion Pharmaceuticals | 1 | $18 |
| Aspira Women's Health Inc | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $12 |
How this compares
$2,700 in reported general payments places this provider in the 80th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 34 | $3,878 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Los Angeles
- Malcolm MunroLos Angeles$609K
- Ramon YeraLos Angeles$296K
- Ritu SalaniLos Angeles$158K
- Aela PaizLos Angeles$131K
- Roy SilverLos Angeles$57K
- Karen MannLos Angeles$50K
- Sebhat AfeworkLos Angeles$42K
- Nicole BenderLos Angeles$35K
- Christine SterlingLos Angeles$30K
- Steve YuNorthridge$964K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.